Overview
Kisaco Research organizes B2B conferences, exhibitions, and communities focused on life sciences and pharma innovation, including AI-driven drug discovery, health equity in clinical trials, and enterprise AI applications. They provide intensively researched programs, influential networking opportunities with industry leaders, and tools like Kisaco Leadership Charts to evaluate vendor strengths and execution capabilities. These events connect early adopters, vendors, and experts across drug development, regulatory strategies, and emerging technologies.
Frequently asked questions
- What pharma-focused events does Kisaco Research host?
- Kisaco Research hosts summits like AI Driven Drug Discovery & Development Summit, Health Equity in Clinical Trials, and events covering AI in drug development, clinical trials, and enterprise AI for pharma, manufacturing, and healthcare sectors.
- How does Kisaco Research support vendor evaluation in life sciences?
- They produce Kisaco Leadership Charts from vendor-supplied data, offering objective rankings of product strengths and execution capacity, alongside conferences for networking and showcasing capabilities.
- What geographies and capabilities are covered by Kisaco Research events?
- Events target global audiences with UK-based operations (London office), focusing on capabilities in AI, drug discovery, regulatory strategies, clinical trials, biologics, small molecules, and health equity across pharma and medtech.